393株近期临床分离株对WIN 49375、头孢噻肟、妥布霉素和哌拉西林的体外药敏试验结果。
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
作者信息
Pohlod D J, Saravolatz L D
出版信息
Antimicrob Agents Chemother. 1984 Mar;25(3):377-9. doi: 10.1128/AAC.25.3.377.
Abstract
The in vitro susceptibilities of 393 recent clinical isolates to WIN 49375, a new quinolone derivative, were determined and concurrently tested with cefotaxime, tobramycin, and piperacillin. In general, members of the family Enterobacteriaceae were not as susceptible to tobramycin and piperacillin as they were to WIN 49375. Methicillin-resistant and -susceptible Staphylococcus aureus were equally susceptible to WIN 49375.
摘要
测定了393株近期临床分离株对新型喹诺酮衍生物WIN 49375的体外敏感性，并同时与头孢噻肟、妥布霉素和哌拉西林进行了测试。一般来说，肠杆菌科成员对妥布霉素和哌拉西林的敏感性不如对WIN 49375的敏感性高。耐甲氧西林和甲氧西林敏感的金黄色葡萄球菌对WIN 49375的敏感性相同。
相似文献
1
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.393株近期临床分离株对WIN 49375、头孢噻肟、妥布霉素和哌拉西林的体外药敏试验结果。
Antimicrob Agents Chemother. 1984 Mar;25(3):377-9. doi: 10.1128/AAC.25.3.377.
2
Activity of ciprofloxacin against resistant clinical isolates.环丙沙星对耐药临床分离株的活性。
J Antimicrob Chemother. 1986 Mar;17(3):281-6. doi: 10.1093/jac/17.3.281.
3
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.A-56619（二氟沙星）和A-56620：新型芳基氟喹诺酮类药物的体外评价
Antimicrob Agents Chemother. 1986 Feb;29(2):193-200. doi: 10.1128/AAC.29.2.193.
4
In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).氟喹诺酮类药物WIN 49375（阿米氟沙星）的体外和体内抗菌活性
Antimicrob Agents Chemother. 1985 Jan;27(1):4-10. doi: 10.1128/AAC.27.1.4.
5
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.新型4-喹诺酮衍生物RO 23-6240（氟罗沙星）的体外活性比较
Eur J Clin Microbiol. 1987 Aug;6(4):482-5. doi: 10.1007/BF02013116.
6
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.新型二氟喹诺酮抗菌剂替马沙星的体外活性
Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):58-63. doi: 10.1007/BF01962176.
7
In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.与其他抗生素相比，WIN 49375对癌症患者分离菌株的体外活性。
Antimicrob Agents Chemother. 1984 Sep;26(3):421-3. doi: 10.1128/AAC.26.3.421.
8
In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.阿米氟沙星（WIN 49,375）与环丙沙星和氧氟沙星的体外活性比较。
Acta Pathol Microbiol Immunol Scand B. 1987 Feb;95(1):29-32. doi: 10.1111/j.1699-0463.1987.tb03083.x.
9
Antimicrobial spectrum of Win 49375.Win 49375的抗菌谱
Antimicrob Agents Chemother. 1984 Jul;26(1):104-7. doi: 10.1128/AAC.26.1.104.
10
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.双效抗菌剂Ro 23-9424及对照剂的体外活性
Antimicrob Agents Chemother. 1989 Jul;33(7):1072-7. doi: 10.1128/AAC.33.7.1072.
引用本文的文献
1
Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.阿米氟沙星对明确的耐庆大霉素革兰氏阴性菌的活性。
Antimicrob Agents Chemother. 1984 Nov;26(5):781-4. doi: 10.1128/AAC.26.5.781.
2
Metabolism and disposition of amifloxacin in laboratory animals.阿米氟沙星在实验动物体内的代谢与处置
Antimicrob Agents Chemother. 1985 May;27(5):774-81. doi: 10.1128/AAC.27.5.774.
3
In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).氟喹诺酮类药物WIN 49375（阿米氟沙星）的体外和体内抗菌活性
Antimicrob Agents Chemother. 1985 Jan;27(1):4-10. doi: 10.1128/AAC.27.1.4.
4
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.氟喹诺酮类。对其作用方式、抗菌活性、药代动力学及临床疗效的综述。
Pharm Weekbl Sci. 1986 Feb 21;8(1):1-21. doi: 10.1007/BF01975473.
5
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.新型氟喹诺酮类药物E-3846在体外以及大鼠实验性膀胱炎和肾盂肾炎中的活性
Antimicrob Agents Chemother. 1988 May;32(5):636-41. doi: 10.1128/AAC.32.5.636.
6
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.A-56619（二氟沙星）和A-56620：新型芳基氟喹诺酮类药物的体外评价
Antimicrob Agents Chemother. 1986 Feb;29(2):193-200. doi: 10.1128/AAC.29.2.193.
7
Quinolones: pharmacology.喹诺酮类：药理学
Pharm Weekbl Sci. 1986 Feb 21;8(1):22-5. doi: 10.1007/BF01975474.
8
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.氟喹诺酮类药物：结构、作用机制与耐药性以及体外活性谱
Antimicrob Agents Chemother. 1985 Oct;28(4):581-6. doi: 10.1128/AAC.28.4.581.
9
In vitro activities of amifloxacin and two of its metabolites.阿米氟沙星及其两种代谢物的体外活性。
Antimicrob Agents Chemother. 1989 May;33(5):762-6. doi: 10.1128/AAC.33.5.762.
10
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
本文引用的文献
1
Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S300-15. doi: 10.1093/clinids/4.supplement_2.s300.
2
Clinical efficacy of cefotaxime in serious infections.头孢噻肟在严重感染中的临床疗效。
Antimicrob Agents Chemother. 1982 Jan;21(1):119-24. doi: 10.1128/AAC.21.1.119.
3
Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.诺氟沙星与其他十五种抗假单胞菌药物对庆大霉素敏感和耐药铜绿假单胞菌菌株的比较活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):602-4. doi: 10.1128/AAC.24.4.602.
4
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.环丙沙星（拜奥9867）、诺氟沙星、吡哌酸和萘啶酸的比较活性。
Antimicrob Agents Chemother. 1983 Aug;24(2):302-4. doi: 10.1128/AAC.24.2.302.
5
In vitro studies of piperacilin, a new semisynthetic penicillin.新型半合成青霉素哌拉西林的体外研究。
Antimicrob Agents Chemother. 1978 Jun;13(6):944-50. doi: 10.1128/AAC.13.6.944.
6
Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.哌拉西林，一种新型青霉素，对许多耐其他青霉素的细菌有活性。
Antimicrob Agents Chemother. 1978 Mar;13(3):358-67. doi: 10.1128/AAC.13.3.358.
Zotero 插件